Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Common Stock · CUSIP: 690469101
Event date: 2025-11-28
- Filing-level shares
- 7,114,114
- Percent of class
- 9.99%
- JANUS HENDERSON GROUP PLC
Shares: 7,114,114 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000340
- Form type
- SCHEDULE 13G
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Dec 08, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership